These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current pharmacotherapy for acromegaly: a review. Biermasz NR; Romijn JA; Pereira AM; Roelfsema F Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571 [TBL] [Abstract][Full Text] [Related]
6. Medical therapy of acromegaly: efficacy and safety of somatostatin analogues. Feelders RA; Hofland LJ; van Aken MO; Neggers SJ; Lamberts SW; de Herder WW; van der Lely AJ Drugs; 2009 Nov; 69(16):2207-26. PubMed ID: 19852525 [TBL] [Abstract][Full Text] [Related]
7. Current management of acromegaly. Díez JJ; Iglesias P Expert Opin Pharmacother; 2000 Jul; 1(5):991-1006. PubMed ID: 11249504 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of pituitary adenomas. Chanson P; Salenave S Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological approach to the treatment of acromegaly. Ezzat S Neurosurg Focus; 2004 Apr; 16(4):E3. PubMed ID: 15191332 [TBL] [Abstract][Full Text] [Related]
10. Role of medical therapy in the management of acromegaly. Vance ML; Laws ER Neurosurgery; 2005 May; 56(5):877-85; discussion 877-85. PubMed ID: 15854234 [TBL] [Abstract][Full Text] [Related]
11. New perspectives in the medical treatment of acromegaly. Colao A; Pivonello R; Auriemma RS; Galdiero M; Guerra E; Milone F; De Leo M; Lombardi G J Endocrinol Invest; 2005; 28(11 Suppl International):58-66. PubMed ID: 16625847 [TBL] [Abstract][Full Text] [Related]
12. Acromegaly. Scacchi M; Cavagnini F Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948 [TBL] [Abstract][Full Text] [Related]
13. Current therapy and drug pipeline for the treatment of patients with acromegaly. Kumar SS; Ayuk J; Murray RD Adv Ther; 2009 Apr; 26(4):383-403. PubMed ID: 19444656 [TBL] [Abstract][Full Text] [Related]
14. Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. Clemmons DR; Chihara K; Freda PU; Ho KK; Klibanski A; Melmed S; Shalet SM; Strasburger CJ; Trainer PJ; Thorner MO J Clin Endocrinol Metab; 2003 Oct; 88(10):4759-67. PubMed ID: 14557452 [TBL] [Abstract][Full Text] [Related]
15. [Advances in the treatment of acromegaly]. Krysiak R; Okopień B; Marek B Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic management of acromegaly]. Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810 [TBL] [Abstract][Full Text] [Related]
17. Medical management of growth hormone-secreting pituitary adenomas. Racine MS; Barkan AL Pituitary; 2002; 5(2):67-76. PubMed ID: 12675503 [TBL] [Abstract][Full Text] [Related]
18. Current therapy for acromegaly. Stewart PM Trends Endocrinol Metab; 2000; 11(4):128-32. PubMed ID: 10754533 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma]. Schäffler A Internist (Berl); 2006 Dec; 47(12):1215-6, 1218-20, 1222. PubMed ID: 17033781 [TBL] [Abstract][Full Text] [Related]